AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced that its Ibis program has been granted three new government contracts valued at up to $10 million for the continued development of its TIGER biosensor technology.
TIGER, which stands for Triangulation Identification Genetic Evaluation of Risks, is a research program initially sponsored by the Defense Advanced Research Projects Agency (DARPA) under a subcontract from Science Applications International Corporation (SAIC) for bioweapons defense.
The TIGER program is also funded by the Centers for Disease Control and Prevention (CDC) for epidemiological surveillance applications, the Federal Bureau of Investigation (FBI) for the development of a microbial agent database, and by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, for biological products screening.
Together with prior awards, Ibis has received contracts for up to $65 million in funding from multiple government agencies.
The development of TIGER's biological products screening application will be ...
Source: HighBeam Research, Ibis program granted three new government contracts for up to $10...